Innate immune recognition of molds and homology to the inner ear protein, cochlin, in patients with autoimmune inner ear disease

Journal of Clinical Immunology

Volumn 33, Issue 7, 2013, Pages 1204-1215

  Pathak, Shresh ^a,c,d   Hatam, Lynda J ^a   Bonagura, Vincent ^a,c   Vambutas, Andrea ^a,b,c,d  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^c HOFSTRA UNIVERSITY   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

autoimmune inner ear disease (AIED); cochlin; Interleukin 1 beta (IL 1 ); LCCL domain; Mold

Indexed keywords

COCHLIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA;

ADULT; AGED; ALTERNARIA; AMINO ACID SEQUENCE; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN RECOGNITION; ARTICLE; ASPERGILLUS NIGER; ASPERGILLUS ORYZAE; ASPERGILLUS REPENS; ASPERGILLUS TERREUS; AUTOIMMUNE DISEASE; AUTOIMMUNE INNER EAR DISEASE; AUTOIMMUNITY; B LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; INNER EAR DISEASE; LYMPHOCYTE DIFFERENTIATION; MALE; MOULD; PENICILLIUM CHRYSOGENUM; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; SUPERNATANT; TH17 CELL; UPREGULATION;

ADULT; AGED; ANTIBODIES, FUNGAL; ANTIGENS, FUNGAL; ASPERGILLOSIS; ASPERGILLUS; AUTOIMMUNE DISEASES; CELLS, CULTURED; CROSS REACTIONS; CYTOKINES; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; LABYRINTH DISEASES; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84885183813     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-013-9926-x     Document Type: Article

References (63)

1. McCabe BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1979;88:585-9.
2. Bovo R, Ciorba A, Martini A. The diagnosis of autoimmune inner ear disease: evidence and critical pitfalls. Eur Arch Otorhinolaryngol. 2009;266:37-40.
3. Bowman CA, Nelson RA. Human leukocytic antigens in autoimmune sensorineural hearing loss. Laryngoscope. 1987;97:7-9.
4. Satoh H, Firestein GS, Billings PB, Harris JP, Keithley EM. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope. 2002;112:1627-34.
5. Svrakic M, Pathak S, Goldofsky E, Hoffman R, Chandrasekhar SS, Sperling N, et al. Diagnostic and prognostic utility of measuring tumor necrosis factor in the peripheral circulation of patients with immune.-mediated sensorineural hearing loss. Arch Otolaryngol Head Neck Surg. 2012;138:1052-8.
6. Pathak S, Goldofsky E, Vivas EX, Bonagura VR, Vambutas A. IL-1beta is overexpressed and aberrantly regulated in corticosteroid nonresponders with autoimmune inner ear disease. J Immunol. 2011;186:1870-9.
7. Hirose K, Discolo CM, Keasler JR, Ransohoff R. Mononuclear phagocytes migrate into the murine cochlea after acoustic trauma. J Comp Neurol. 2005;489:180-94.
8. Manolis EN, Yandavi N, Nadol Jr JB, Eavey RD, McKenna M, Rosenbaum S, et al. A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12-13. Hum Mol Genet. 1996;5:1047-50.
9. Robertson NG, Skvorak AB, Yin Y, Weremowicz S, Johnson KR, Kovatch KA, et al. Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics. 1997;46:345-54.
10. Robertson NG, Hamaker SA, Patriub V, Aster JC, Morton CC. Subcellular localisation, secretion, and post-translational processing of normal cochlin, and of mutants causing the sensorineural deafness and vestibular disorder, DFNA9. J Med Genet. 2003;40:479-86.
11. Boulassel MR, Tomasi JP, Deggouj N, Gersdorff M. COCH5B2 is a target antigen of anti-inner ear antibodies in autoimmune inner ear diseases. Otol Neurotol. 2001;22:614-8.
12. Baek MJ, Park HM, Johnson JM, Altuntas CZ, Jane-Wit D, Jaini R, et al. Increased frequencies of cochlin-specific T cells in patients with autoimmune sensorineural hearing loss. J Immunol. 2006;177:4203-10.
13. Niparko JK, Wang NY, Rauch SD, Russell GB, Espeland MA, Pierce JJ, et al. Serial audiometry in a clinical trial of AIED treatment. Otol Neurotol. 2005;26:908-17.
14. Hughes GB, Kinney SE, Barna BP, Calabrese LH. Autoimmune reactivity in Meniere's disease: a preliminary report. Laryngoscope. 1983;93:410-7.
15. Barna BP, Hughes GB. Autoimmunity and otologic disease: clinical and experimental aspects. Clin Lab Med. 1988;8:385-98.
16. Gazquez I, Soto-Varela A, Aran I, Santos S, Batuecas A, Trinidad G, et al. High prevalence of systemic autoimmune diseases in patients with Meniere's disease. PLoS One. 2011;6:e26759.
17. Derebery MJ, Berliner KI. Prevalence of allergy in Meniere's disease. Otolaryngol Head Neck Surg. 2000;123:69-75.
18. Banks C, McGinness S, Harvey R, Sacks R. Is allergy related to Meniere's disease? Curr Allergy Asthma Rep. 2012;12:255-60.
19. Eaton DA, Roland PS, Mabry RL, Shoup AG. Electrocochleography and intranasal allergen challenge as investigational tools in patients with inhalant allergy and Meniere's disease. Laryngoscope. 2003;113:33-6.
20. Toubi E, Ben-David J, Kessel A, Halas K, Sabo E, Luntz M. Immune-mediated disorders associated with idiopathic sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol. 2004;113:445-9.
21. Fujioka M, Kanzaki S, Okano HJ, Masuda M, Ogawa K, Okano H. Proinflammatory cytokines expression in noise-induced damaged cochlea. J Neurosci Res. 2006;83:575-83.
22. Hashimoto S, Billings P, Harris JP, Firestein GS, Keithley EM. Innate immunity contributes to cochlear adaptive immune responses. Audiol Neurootol. 2005;10:35-43.
23. Vambutas A, DeVoti J, Goldofsky E, Gordon M, Lesser M, Bonagura V. Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED. PLoS One. 2009;4:e5293.
24. Said-Sadier N, Padilla E, Langsley G, Ojcius DM. Aspergillus fumigatus stimulates the NLRP3 inflammasome through a pathway requiring ROS production and the Syk tyrosine kinase. PLoS One. 2010;5:e10008.
25. Nicholson WJ, Slight J, Donaldson K. Inhibition of the transcription factors NF-kappa B and AP-1 underlies loss of cytokine gene expression in rat alveolar macrophages treated with a diffusible product from the spores of Aspergillus fumigatus. Am J Respir Cell Mol Biol. 1996;15:88-96.
26. Warris A, Netea MG, Verweij PE, Gaustad P, Kullberg BJ, Weemaes, et al. Cytokine responses and regulation of interferon-gamma release by human mononuclear cells to Aspergillus fumigatus and other filamentous fungi. Med Mycol. 2005;43:613-21.
27. Morgenstern DE, Gifford MA, Li LL, Doerschuk CM, Dinauer MC. Absence of respiratory burst in X-linked chronic granulomatous disease mice leads to abnormalities in both host defense and inflammatory response to Aspergillus fumigatus. J Exp Med. 1997;185:207-18.
28. Dinarello CA. Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 2011;117:3720-32.
29. Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol. 2011;41:1203-17.
30. Wilson NJ, Boniface K, Chan JR, McKenzie BS, Blumenschein WM, Mattson JD, et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol. 2007;8:950-7.
31. Acosta-Rodriguez EV, Napolitani G, Lanzavecchia A, Sallusto F. Interleukins 1beta and 6 but not transforming growth factor-beta are essential for the differentiation of interleukin 17-producing human T helper cells. Nat Immunol. 2007;8:942-9.
32. Sutton C, Brereton C, Keogh B, Mills KH, Lavelle EC. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis. J Exp Med. 2006;203:1685-91.
33. Duan J, Chung H, Troy E, Kasper DL. Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe. 2010;7:140-50.
34. Chung Y, Chang SH, Martinez GJ, Yang XO, Nurieva R, Kang HS, et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity. 2009;30:576-87.
35. Nakae S, Saijo S, Horai R, Sudo K, Mori S, Iwakura Y. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist. Proc Natl Acad Sci U S A. 2003;100:5986-90.
36. Aggarwal S, Gurney AL. IL-17: prototype member of an emerging cytokine family. J Leukoc Biol. 2002;71:1-8.
37. Moseley TA, Haudenschild DR, Rose L, Reddi AH. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev. 2003;14:155-74.
38. Kolls JK, Linden A. Interleukin-17 family members and inflammation. Immunity. 2004;21:467-76.
39. Lasiglie D, Traggiai E, Federici S, Alessio M, Buoncompagni A, Accogli A, et al. Role of IL-1 beta in the development of human T(H)17 cells: lesson from NLPR3 mutated patients. PLoS One. 2011;6:e20014.
40. Yssel H, Spits H. Generation and maintenance of cloned human T cell lines. Curr Protoc Immunol. 2002. doi: 10.1002/0471142735.im0719s47.
41. Greco A, Gallo A, Fusconi M, Marinelli C, Macri GF, de Vincentiis M. Meniere's disease might be an autoimmune condition? Autoimmun Rev. 2012;11:731-8.
42. Ford ML, Evavold BD. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide: MHC complexes. Mol Immunol. 2004;40:1019-25.
43. Cao MY, Thonnard J, Deggouj N, Gersdorff M, Philippe M, Osselaer JC, et al. HLA class II-associated genetic susceptibility in idiopathic progressive sensorineural hearing loss. Ann Otol Rhinol Laryngol. 1996;105(8):628-33.
44. Wang P, Sidney J, Kim Y, Sette A, Lund O, Nielsen M, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinforma. 2010;11:568.
45. Wang P, Sidney J, Dow C, Mothé B, Sette A, Peters B. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol. 2008;4:e1000048.
46. Bozza S, Zelante T, Moretti S, Bonifazi P, DeLuca A, D'Angelo C, et al. Lack of Toll IL-1R8 exacerbates Th17 cell responses in fungal infection. J Immunol. 2008;180:4022-31.
47. Bowyer P, Fraczek M, Denning DW. Comparative genomics of fungal allergens and epitopes shows widespread distribution of closely related allergen and epitope orthologues. BMC Genomics. 2006;7:251.
48. Guarneri F, Guarneri B, Vaccaro M, Guarneri C. The human Ku autoantigen shares amino acid sequence homology with fungal, but not bacterial and viral, proteins. Immunopharmacol Immunotoxicol. 2011;33:329-33.
49. Guarneri F, Guarneri B, Borgia F, Guarneri C. Potential role of molecular mimicry between human U1-70 kDa and fungal proteins in the development of T-cell mediated anti-U1-70 kDa autoimmunity. Immunopharmacol Immunotoxicol. 2011;33:620-5.
50. Agrup C, Luxon LM. Immune-mediated inner-ear disorders in neuro-otology. Curr Opin Neurol. 2006;19:26-32.
51. Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature. 1986;324(6092):73-6.
52. Meng G, Zhang F, Fuss I, Kitani A, Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity. 2009;30:860-74.
53. Nakano S, Morimoto S, Suzuki J, Nozawa K, Amano H, Tokano Y, et al. Role of pathogenic auto-antibody production by Toll-like receptor 9 of B cells in active systemic lupuserythematosus. Rheumatology (Oxford). 2008;47(2):145-9.
54. Smirnova I, Poltorak A, Chan EK, McBride C, Beutler B. Phylogenetic variation and polymorphism at the toll-like receptor 4 locus (TLR4). Genome Biol. 2000. doi: 10.1186/gb-2000-1-1research002.
55. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M, et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol. 2006;177(1):322-32.
56. Schmitt C, Humeny A, Becker CM, Brune K, Pahl A. Polymorphisms of TLR4: rapid genotyping and reduced response to lipopolysaccharide of TLR4 mutant alleles. Clin Chem. 2002;48(10):1661-7.
57. Bourgeois C, Kuchler K. Fungal pathogens-a sweet and sour treat for toll-like receptors. Front Cell Infect Microbiol. 2012;2:142. doi: 10.3389/fcimb.2012.00142.
58. Requena T, Gazquez I, Moreno A, Batuecas A, Aran I, Soto-Varela A, et al. Allelic variants in TLR10 gene may influence bilateral affectation and clinical course of Meniere's disease. Immunogenetics. 2013;65(5):345-55.
59. Rice P, Longden I, Bleasby A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 2000;16(6):276-7.
60. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med. 2000;191:313-20.
61. Tanoue T, Umesaki Y, Honda K. Immune responses to gut microbiota-commensals and pathogens. Gut Microbes. 2010;1:224-33.
62. Zelante T, De Luca A, Bonifazi P, Montagnoli C, Bozza S, Moretti S, et al. IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur J Immunol. 2007;37:2695-706.
63. Zelante T, Bozza S, De Luca A, D'Angelo C, Bonifazi P, Moretti S, et al. Th17 cells in the setting of Aspergillus infection and pathology. Med Mycol. 2009;47 Suppl 1:S162-9.